Share

Endocrine-Disrupting Chemical Tributyltin Alters Stem Cell Adipose Lineage

In yet another indictment of endocrine-disrupting chemicals, researchers have found a mechanism through which tributyltin (TBT) causes obesity and alters adipose lineage, according to an article recently published in Endocrinology. The researchers, led by Bruce Blumberg, PhD, of the University of California, Irvine, point out that nearly 40 percent of American adults are now obese,...
Share

Differential Diagnoses Should Be Considered in Patients with Features of Acromegaly without Excess GH Secretion

JES_Cover_FINAL A paper published recently in the Journal of the Endocrine Society details a case of a woman with acromegaly-like features, but she did not have excess growth hormone (GH) secretion. The authors use the case to show that differential diagnoses should be considered in these patients with “pseudoacromegaly” or “acromegaloidism.” The paper, by Per Dahlqvist,...
Share

Addressing Controversies in Managing Low-Risk Differentiated Thyroid Cancer

A paper recently published in Endocrine Reviews is addressing the controversies that exist in managing low-risk differentiated thyroid cancer (DTC), since these controversies expose patients to the risk of being over- or undertreated. The review, by Megan R. Haymart, MD, of the University of Michigan, et al, points out that the controversies extend across all...
Share

Long-Term Diabetes Complication: Liver Inflammation Raises Cholesterol Levels

Inflammatory processes in the liver lead to elevated cholesterol levels in people with diabetes, thus promoting subsequent vascular diseases, according to a study by researchers at Helmholtz Zentrum München, Technische Universität München (TUM) and the Collaborative Research Center SFB 1118 at Heidelberg University Hospital. The paper was recently published in Cell Reports. “Even if blood...
Share

Machine-Learning Techniques Unlock Hidden Benefit of Weight Loss Interventions for Overweight Patients with Type 2 Diabetes

Losing weight reduces the risk of long-term cardiovascular illness and mortality for the majority of patients with type 2 diabetes, but for a small subgroup, weight-loss intervention can lead to dramatically worse outcomes, according a study published recently in The Lancet Diabetes & Endocrinology. Researchers led by James H. Faghmous, PhD, chief technology officer at...